Clinical Trials Directory

Trials / Completed

CompletedNCT00292162

Curing Atrial Fibrillation in Heart Failure

Radiofrequency Ablation for Atrial Fibrillation in Advanced Chronic Heart Failure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
NHS Greater Glasgow and Clyde · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Heart failure is a condition that occurs when the heart muscle weakens and no longer contracts normally. Half of these patients have an irregularity of heart rhythm called atrial fibrillation (AF). Patients with both heart failure and AF spend more time in hospital, and die earlier than those with heart failure alone. AF is difficult to treat with conventional methods in patients with heart failure. Radiofrequency ablation is a new technique used to cure AF. The investigators aim to establish if radiofrequency ablation for atrial fibrillation in patients with advanced heart failure can result in marked improvement in the function of the heart.

Conditions

Interventions

TypeNameDescription
PROCEDUREradiofrequency ablationisolation of the pulmonary veins with radiofrequency ablation (RFA)
DRUGACE inhibitor - ramipril, enalapril, captopril, perindopril, lisinoprilEvidence based treatment for heart failure. Dose and type will depend on patient tolerability.
DRUGBeta Blocker (BB) - metoprolol, bisoprolol, carvedilolEvidence based treatment for heart failure. Dose and type will depend on patient tolerance.
DRUGAldosterone Antagonists - spironolactoneEvidence based treatment for heart failure. Dose and type will depend on patient to treatment.

Timeline

Start date
2007-01-01
Primary completion
2009-07-01
Completion
2009-07-01
First posted
2006-02-15
Last updated
2012-06-01
Results posted
2012-06-01

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00292162. Inclusion in this directory is not an endorsement.